EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of the D8P1C1 Anti-ADAM17 Inhibitory Monoclonal Antibody and Generation of Its Bispecific T-Cell Engager Derivative

Nayanendu Saha, Sang Gyu Lee, Elisa de Stanchina, Rachelle P Mendoza, Darren R Veach iD, Dimitar B Nikolov iD

International Journal of Molecular Sciences · 24.03.2026 · 27 (7) · 2936

DOI: 10.3390/ijms27072936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.03.2026. Verfasst von Nayanendu Saha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Hauptthemen laut MEDLINE: ADAM17 Protein, Antibodies, Monoclonal, Antibodies, Bispecific, Ovarian Neoplasms. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Experimental Therapeutics Center of Memorial Sloan Kettering, Commonwealth Foundation for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

EGFR signaling, which requires ligand shedding by ADAM proteases, drives the progression of a variety of cancers, including breast, ovarian and lung. We previously reported the generation and characterization of a fully human, affinity-matured anti-ADAM17 monoclonal antibody, D8P1C1, which inhibits both the proliferation of an array of cancer cell lines in vitro as well as breast cancer growth in a mouse xenograft model. Here, we show that the mAb inhibits the shedding of EGFR ligands and EGFR phosphorylation in cancer cell lines, thus explaining its anti-tumor effects. In a xenograft model with a high-grade serous ovarian cancer (HGSOC) cell line, D8P1C1 showed only modest therapeutic effect, without any discernible toxicity. These results suggest that ovarian cancers are less susceptible than breast cancers to therapeutic targeting of ADAM17- or EGFR-dependent signaling. Radioimmuno PET imaging with 89Zr-DFO-D8P1C1 confirmed tumoral accumulation of the mAb in high-grade and non-high-grade serous ovarian tumor xenografts. Furthermore, we report the generation and preliminary characterization of a bispecific T cell engager derivative of D8P1C1 with improved anti-tumor efficacy in vitro.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM17 ProteinAntibodies, MonoclonalAntibodies, BispecificOvarian NeoplasmsT-LymphocytesHumansAnimalsFemaleMiceCell Line, TumorXenograft Model Antitumor AssaysErbB ReceptorsCell ProliferationSignal Transduction

Stichwörter der Autor:innen

ADAM17EGFR signalingbispecific T-cell engagerhigh-grade serous ovarian cancer

Substanzen

ADAM17 ProteinAntibodies, MonoclonalAntibodies, BispecificErbB ReceptorsADAM17 protein, human

Autor:innen und Institutionen

  • Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Antitumor Assessment Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.

ORCID-Profile: Darren R Veach, Dimitar B Nikolov

Förderung

  • NCI NIH HHS
  • Experimental Therapeutics Center of Memorial Sloan Kettering
  • Commonwealth Foundation for Cancer Research
  • Technology Development Investment Fund of Memorial Sloan Kettering
  • NIH/NCI Cancer Center

Zitieren

APA

Saha, N., Lee, S. G., de Stanchina, E., Mendoza, R. P., Veach, D. R., & Nikolov, D. B. (2026). Characterization of the D8P1C1 Anti-ADAM17 Inhibitory Monoclonal Antibody and Generation of Its Bispecific T-Cell Engager Derivative. International Journal of Molecular Sciences, 27(7), 2936. https://doi.org/10.3390/ijms27072936

Vancouver

Saha N, Lee SG, de Stanchina E, Mendoza RP, Veach DR, Nikolov DB. Characterization of the D8P1C1 Anti-ADAM17 Inhibitory Monoclonal Antibody and Generation of Its Bispecific T-Cell Engager Derivative. International Journal of Molecular Sciences. 2026;27(7):2936. doi:10.3390/ijms27072936

BibTeX
@article{Saha2026,
  author = {Saha, Nayanendu and Lee, Sang Gyu and de Stanchina, Elisa and Mendoza, Rachelle P and Veach, Darren R and Nikolov, Dimitar B},
  title = {Characterization of the D8P1C1 Anti-ADAM17 Inhibitory Monoclonal Antibody and Generation of Its Bispecific T-Cell Engager Derivative},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {2936},
  doi = {10.3390/ijms27072936}
}
Kostenlos starten →